Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)
Clinical trial NCT03855865 · WITHDRAWN
Trial details
- NCT number
- NCT03855865
- Sponsor
- Naurex, Inc, an affiliate of Allergan plc
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.